Women In Steady Exercise Research (WISER) Sister: Study design and methods

Contemporary Clinical Trials

Volumn 41, Issue , 2015, Pages 17-30

  Schmitz, Kathryn H ^a   Williams, Nancy I ^b   Kontos, Despina ^a   Kurzer, Mindy S ^c   Schnall, Mitchell ^a   Domchek, Susan ^a   Stopfer, Jill ^a   Galantino, Mary Lou ^d   Hwang, Wei Ting ^a   Morales, Knashawn ^a   Wu, Shandong ^e   DiGiovanni, Laura ^a   Salvatore, Domenick ^a   Fenderson, Desire' ^a   Good, Jerene ^a   Sturgeon, Kathleen ^a   Grant, Lorita ^a   Bryan, Cathy J ^a   Adelman, Jess ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d RICHARD STOCKTON COLLEGE OF NEW JERSEY   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA mutation; Breast cancer; Exercise; MR imaging; Sex hormones

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL RESEARCH; CONTROLLED STUDY; E-MAIL; EXERCISE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE; UNITED STATES; URINALYSIS; BLOOD; BREAST; BREAST NEOPLASMS; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; KINESIOTHERAPY; MUTATION; PATHOLOGY; PROCEDURES; RISK REDUCTION; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE; URINE;

ADIPONECTIN; ESTRONE; LEPTIN; PREGNANEDIOL;

ADIPONECTIN; ADULT; BREAST; BREAST NEOPLASMS; ESTRONE; EXERCISE THERAPY; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; LEPTIN; MAGNETIC RESONANCE IMAGING; MUTATION; PREGNANEDIOL; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 84920744798     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2014.12.016     Document Type: Article

References (59)

1. Domchek S.M., Friebel T.M., Singer C.F., Evans D.G., Lynch H.T., Isaacs C., et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010, 304:967-975.
2. Narod S.A. Modifiers of risk of hereditary breast cancer. Oncogene 2006, 25:5832-5836.
3. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., Melton L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006, 7:821-828.
4. Parker E., Schmitz K., Dengel D.R., Schreiner P.J., Jacobs D.R. Physical Activity in young adults and incident hypertension over fifteen years of follow up: the CARDIA study. Am J Public Health 2007, 97:703-709.
5. Artinian N.T., Fletcher G.F., Mozaffarian D., Kris-Etherton P., Van Horn L., Lichtenstein A.H., et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 2010, 122:406-441.
6. Fletcher J.A. Canadian Academy of Sport and Exercise Medicine position statement: osteoporosis and exercise. Clin J Sport Med 2013, 23:333-338.
7. Wroblewski A.P., Amati F., Smiley M.A., Goodpaster B., Wright V. Chronic exercise preserves lean muscle mass in masters athletes. Phys Sportsmed 2011, 39:172-178.
8. Williams N.I., Reed J.L., Leidy H.J., Legro R.S., De Souza M.J. Estrogen and progesterone exposure is reduced in response to energy deficiency in women aged 25-40years. Hum Reprod 2010, 25:2328-2339.
9. King M.C., Marks J.H., Mandell J.B., New York Breast Cancer Study Group Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003, 302:643-646. [see comment].
10. Kotsopoulos J., Olopado O.I., Ghadirian P., Lubinski J., Lynch H.T., Isaacs C., et al. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005, 7:R833-R843.
11. Rundle A. Molecular epidemiology of physical activity and cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:227-236.
12. Hankinson S., Willett W., Manson J., Colditz G., Hunter D., Spiegelman D., et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998, 90:1292-1299.
13. Hankinson S.E. Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 2005, 24:3-15.
14. Eliassen A.H., Missmer S.A., Tworoger S.S., Spiegelman D., Barbieri R.L., Dowsett M., et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006, 98:1406-1415.
15. Arikawa A.Y., O'Dougherty M., Kaufman B.C., Smith A.J., Thomas W., Warren M., et al. Women in Steady Exercise Research (WISER): study design and methods. Contemp Clin Trials 2010, 31:457-465.
16. Anton-Culver H., Ziogas A., Bowen D., Finkelstein D., Griffin C., Hanson J., et al. The Cancer Genetics Network: recruitment results and pilot studies. Community Genet 2003, 6:171-177.
17. Peacey V., Steptoe A., Davidsdottir S., Baban A., Wardle J. Low levels of breast cancer risk awareness in young women: an international survey. Eur J Cancer 2006, 42:2585-2589.
18. Gail M.H., Brinton L.A., Byar D.P., Corle D.K., Green S.B., Schairer C., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886.
19. Claus E.B., Risch N., Thompson W.D. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994, 73:643-651.
20. Stice E., Telch C.F., Rizvi S.L. Development and validation of the Eating Disorder Diagnostic Scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder. Psychol Assess 2000, 12:123-131.
21. Pescatello L.S., Arena R., Riebe D., Thompson P.D. ACSM's guidelines for exercise testing and prescription 2013, Lippincott Williams & Wilkins, Philadelphia, PA. 9th ed.
22. O'Connor K.A., Brindle E., Holman D.J., Klein N.A., Soules M.R., Campbell K.L., et al. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem 2003, 49:1139-1148.
23. Ferrell R.J., O'Connor K.A., Rodriguez G., Gorrindo T., Holman D.J., Brindle E., et al. Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age. Menopause 2005, 12:567-577.
24. Boeniger M.F., Lowry L.K., Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: a review. Am Ind Hyg Assoc J 1993, 54:615-627.
25. Srivastava S., Mani K., Soni C. Effect of muscular exercise on urinary excretion of creatine and creatinine. J Med Res 1957, 55:953-960.
26. Guthrie R.M., Lott J.A., Kriesel S., Miller I.L. Does the dipstick meet medical needs for urine specific gravity?. J Fam Pract 1987, 25:512-514.
27. Goldenberger B., Lowenthal B., Darwin W., Cone E. Intrasubject variation of creatinine and specific gravity measurements in consecutive urine specimens of herion users. Clin Chem 1995, 41:116-1147.
28. Haddow J.E., Knight G.J., Palomaki G.E., Neveux L.M., Chilmonczyk B.A. Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations. Clin Chem 1994, 40:562-564.
29. Pettersson K., Alfthan H., Stenman U.H., Turpeinen U., Suonpaa M., Soderholm J., et al. Simultaneous assay of alpha-fetoprotein and free beta subunit of human chorionic gonadotropin by dual-label time-resolved immunofluorometric assay. Clin Chem 1993, 39:2084-2089.
30. Kriska A.M., Knowler W.C., LaPorte R.E., Drash A.L., Wing R.R., Blair S.N., et al. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990, 13:401-411.
31. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:S498-S516.
32. Bruce R.A., Kusumi F., Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973, 85:546-562.
33. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970, 2:92-98.
34. Subar A.F., Thompson F.E., Kipnis V., Midthune D., Hurwitz P., McNutt S., et al. Comparative validation of the Block, Willett and National Cancer Institute food frequency questionnaires. Am J Epidemiol 2001, 154:1089-1099.
35. King V., Brooks J.D., Bernstein J.L., Reiner A.S., Pike M.C., Morris E.A. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 2011, 260:50-60.
36. Boston R.C., Schnall M.D., Englander S.A., Landis J.R., Moate P.J. Estimation of the content of fat and parenchyma in breast tissue using MRI T1 histograms and phantoms. Magn Reson Imaging 2005, 23:591-599.
37. Hylton N.M. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magn Reson Imaging Clin N Am 2001, 9:321-332. [vi].
38. Wu S., Weinstein S., Kontos D. Atlas-based probabilistic fibroglandular tissue segmentation in breast MRI. Med Image Comput Comput Assist Interv 2012, 15:437-445.
39. Wu S., Weinstein S.P., Conant E.F., Schnall M.D., Kontos D. Automated chest wall line detection for whole-breast segmentation in sagittal breast MR images. Med Phys 2015, 40. [in press].
40. Wu S., Weinstein S.P., Conant E.F., Kontos D. Fully-automated fibroglandular tissue segmentation and volumetric density estimation in breast MRI by integrating a continuous max-flow model and a likelihood atlas. SPIE Medical Imaging: Computer Aided Diagnosis. 2013, 86701C. SPIE Press, Orlando, FL. C. Novak, S. Aylward (Eds.).
41. Wu S., Domchek S.M., DeLeo M.J., Conant E.F., Weinstein S., Kontos D. Effect of risk-reducing salpingo-oophorectomy on breast MRI fibroglandular tissue and background parenchymal enhancement in BRCA1/2 mutation carriers: a quantitative assessment. 2013, International Society for Magnetic Resonance in Medicine Annual Meeting, Salt Lake City, UT.
42. Wu S., Weinstein S.P., Conant E.F., Kontos D. Automated fibroglandular tissue segmentation and volumetric density estimation in breast MRI using an atlas-aided fuzzy C-means method. Med Phys 2013, 40:122302.
43. Wu S., Weinstein S.P., Conant E.F., Schnall M.D., Kontos D. Automated chest wall line detection for whole-breast segmentation in sagittal breast MR images. Med Phys 2013, 40:042301.
44. King V., Goldfarb S.B., Brooks J.D., Sung J.S., Nulsen B.F., Jozefara J.E., et al. Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 2012, 264:670-678.
45. Wu SPW S., Conant E.F., Kontos D. Quantitative background parenchymal enhancement estimation on breast DCE-MRI by measuring relative voxel-wise enhancement. 2013, International Society for Magnetic Resonance in Medicine Annual Meeting, Salt Lake City, UT.
46. Warren M., Schmitz K.H. Safety of strength training in premenopausal women: musculoskeletal injuries from a two-year randomized trial. Am J Health Promot 2009, 23:309-314.
47. Brown J.C., Troxel A.B., Schmitz K.H. Safety of weightlifting among women with or at risk for breast cancer-related lymphedema: musculoskeletal injuries and health care use in a weightlifting rehabilitation trial. Oncologist 2012, 17:1120-1128.
48. USDHHS Physical activity and health: a report of the surgeon general 1996, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA.
49. Donnelly J.E., Blair S.N., Jakicic J.M., Manore M.M., Rankin J.W., Smith B.K. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009, 41:459-471.
50. Munro C., Stbenfeldt G., Cragun J., Addiego L., Overstreet J., Lasley B. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their majority urinary metabolites as measured by enzyme immunoassay and radioassay. Clin Chem 1991, 37:838-844.
51. Beitins I.Z., McArthur J.W., Turnbull B.A., Skrinar G.S., Bullen B.A. Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab 1991, 72:1350-1358.
52. Winters K.M., Adams W.C., Meredith C.N., Loan M.D., Lasley B.L. Bone density and cyclic ovarian function in trained runners and active controls. Med Sci Sports Exerc 1996, 28:776-785.
53. Cohen J. Statistical power analysis in the behavioral sciences 1992, Lawrence Erlbaum, Hillsdale, NY. 2nd ed.
54. Kossman D.A., Williams N.I., Domchek S.M., Kurzer M.S., Stopfer J.E., Schmitz K.H. Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer. J Appl Physiol (1985) 2011, 111:1687-1693.
55. McCullagh P., Nelder J. Generalized linear models 1980, Chapman and Hill, New York. 2nd ed.
56. Littel R., Milliken G., Stroup W., Wolfinger R. SAS system for mixed models 1996, SAS Institute, Inc., Cary, NC.
57. Singer J., Willett J. Applied longitudinal data analysis 2003, Oxford University Press, New York.
58. Fitzmaurice G., Laird N., Ware J. Applied longitudinal analysis 2004, Wiley, Hoboken, New Jersey.
59. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986, 51:1173-1182.